Group items tagged

United States Biopsy Market will cross US$ 17 Billion by the year 2024 owing to the rising prevalence of cancer in the region. According to the World Health Organization, cancer cases are expected to surge 57% worldwide in the next 20 years. Biopsies are most often done to look for cancer; a biopsy is a sample of tissue taken from the body in order to examine it more closely. Further, growing patient awareness and the advancement in the biopsy techniques are also expected to fuel future growth of biopsy market in United States.

Global Waste Management industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Human services investigation is one of the developing territories of social insurance administrations. It broadly utilizes data innovation apparatuses, information, factual and subjective investigation, illustrative and prescient displaying. The investigation help the medicinal services associations in diminishing the doctor's facility remains of patients, meeting administrative consistence, enhanced quality care, prevention of perpetual illnesses, and extortion location.

It is about accuracy of data for each performance category that matters the most in MIPS. As a MIPS Qualified Registry for the fourth time in a row is a living proof of our past performances and current status. In this article, we got a chance to reflect on a few MIPS data essentials; and thought they would be useful for clinicians before the submission window closes for good.

Eligible physicians can improve their financial situation by submitting data under MACRA MIPS. The program empowers physicians and patients alike with quality healthcare & cost efficiency.

Eligible physicians can improve their financial situation by submitting data under MACRA MIPS. The program empowers physicians and patients alike with quality healthcare & cost-efficiency.

Eligible physicians can improve their financial situation by submitting data under MACRA MIPS. The program empowers physicians and patients alike with quality healthcare and cost-efficiency.

Ovarian Cancer Pipeline Analysis" by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Ovarian Cancer. Research report covers all the ongoing drug development in various phases.

Overview: The Sunshine Act, or Open Payments Program, requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain payments and items of value given to physicians and teaching hospitals. This Act was part of a healthcare reform bill adopted in March 2010. It came about due to requests for increased transparency about the financial relationships between physicians and industry. The Centers for Medicare and Medicaid (CMS) issued the final rules in 2013 which implemented the Sunshine Act. Why should you Attend: Anyone required to adhere to the Sunshine Act standards or anyone interested in knowing what must be reported and made public. Areas Covered in the Session: Purpose of the Sunshine Act Who is required to report under the Sunshine Act? What is reported? Exclusions Tracking Penalties Useful links Who Will Benefit: This webinar will provide valuable assistance to all personnel in: Human Subjects Research Healthcare interested in exploring the field of Clinical Research Clinical Research Coordinators Principal Investigators/Physicians Administration in charge of Clinical Research Regulatory Compliance Speaker Profile Sarah Fowler-Dixon is Education Specialist and instructor with Washington University School of Medicine. She has developed a comprehensive education program for human subject research which has served as a model for other institutions. She crafted budgets, policies, procedures, reporting, and training for the new program. She has initiated the planning, development, authorship and implementation of many human subjects research policies, practices, guidelines, submission and reviewer forms often working with state and federal authorities. She has provided consultation regarding ethical, federal, state, and institutional requirements for faculty and staff both in the design and execution of their projects and teaches research ethics and regulatory affairs and the fu

P3 Healthcare Solutions is been offering professional medical billing services for quite some time now. The process starts from the consultation session where providers are informed about every detail from coding, billing to the latest strategies for smoothly running the revenue cycle. We aim to empower physicians with transparent and accurate billing practices.

Here you'll find the official resources to report MIPS 2020; P3Care has a habit of coming up with useful information about the MIPS program. As a CMS MIPS Qualified Registry, in an effort to find the most relevant content for physicians, consider it as another episode.

QPP MIPS participation offers a golden opportunity to target incentives and bonuses. Especially when the CMS has been favoring and rewarding small medical practices then why not take advantage of this chance.

Report and review data to Medicare for the MIPS 2019 performance categories before it's too late. March 31, 2020, is the last date to do it.

Medical billing services for telehealth services as Medicare and Medicaid reimbursements have always been a difficult topic. Treating remote patients and measuring the quality outcomes is indeed not as easy as it seems for physicians.

CMS has always proven to be an authority that speaks in favor of clinicians and address their concerns. Due to the unfortunate situation of coronavirus outbreak, doctors and other clinicians were facing quite some issues regarding submitting data to CMS.

Small Medical Practices! P3Care has been doing well as MIPS Qualified Registry for four years now. During this time, we come up with many little tricks to achieve a minimum performance threshold to be safe from the penalty. Read the article below to know how small practices can avoid the negative payment adjustment in MIPS 2019 reporting.

Revenue cycle management is a major part of a clinician's journey in healthcare. It affects their performances if there are unnecessary delays in the claim submission process as each step of the process has to occur in a timely fashion for revenue optimization.

Physicians! It's time to prepare for the MIPS 2019 reporting period. There's only a little time left. This time may be hectic and stressful, even for MIPS qualified registries. But don't worry, P3 Healthcare Solutions has come up with effective tips to target high MIPS scores. Let's be honest, MIPS QPP can be a daunting approach to earn incentives for those who are not careful.

Before we go into the details, the Merit-based Incentive Payment System (MIPS) comes under the direct obligation of the Medicare Access and CHIP Reauthorization Act (MACRA), the law that regulates the incentive program across the US.

Engagement of patients or consumers of health care is what's required of the system currently. Many health IT vendors continue to work in that direction resulting in a considerable increase in patient engagement.